Horizon Therapeutics Public Limited (HZNP) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Horizon Therapeutics Public Limited Company  (NASDAQ: HZNP)
 

Horizon Therapeutics Public Limited Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HZNP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 7.71 % -6.22 % -1.91 % -2.46 %
Q / Q Revenue Growth (Q2 MRQ) 13.45 % 0.95 % 1.2 % 1.26 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) -4.45 % -4.2 % -2.43 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 1.89 % -1.7 % -2.13 % -0.63 %
Revenue 5 Year Average Growth 28 % 10.99 % 8.94 % 9.55 %


HZNP's Growth Comparisons in II. Quarter 2023




Horizon Therapeutics Public Limited managed to grow Revenue by 7.71% year on year, in the second quarter 2023 to 944 millions, while Major Pharmaceutical Preparations industry fell by -6.22%, Healthcare sector decreased -1.91%. Although Major Pharmaceutical Preparations industry's Sales were softer then -2.46% overall market growth, Horizon Therapeutics Public Limited Company and the Healthcare sector have delivered above average market Sales.

Top-line improved by 13.45% from the first quarter. Looking into annual sales rise of 28%, and S & P 500's average yearly sales growth is 9.55% over the five years, including only Businesses with the second quarter 2023 Results. Horizon Therapeutics Public Limited grew faster than the market.


Growth Rates of HZNP's Income in the second quarter 2023


HZNP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 61.3 % -63.62 % -54.06 % -12.52 %
Sequential Operating Income Change (Q2 MRQ) 296.85 % -60.17 % -56.06 % -4.07 %
Y / Y Operating Income Growth (Q2 TTM) -39.43 % -14.86 % -20.68 % -6.7 %
Sequential Operating Income Growth (Q2 TTM) 11.82 % -15.07 % -10.98 % -3.41 %
Operating Income 5 Year Avg. Change - 15.5 % 4.67 % 8.71 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 108.4 % -80.17 % -94.18 % -12.23 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) 132.37 % -58.66 % -93.7 % -5.88 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -42.74 % -41.62 % -44.75 % -9.06 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 17.77 % -22.17 % -20.07 % -3.4 %
Income from Cont. Ops. 5 Year Avg. Change - 16.52 % 8.32 % 11.88 %

HZNP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 108.4 % -79.99 % -94.3 % -10.4 %
Q / Q Net Income Growth (Q2 MRQ) 132.37 % -58 % -93.84 % -4.29 %
Y / Y Net Income Change (Q2 TTM) -42.74 % -39.59 % -42.78 % -8.96 %
Sequential Net Income Change (Q2 TTM) 17.77 % -21.65 % -19.6 % -2.9 %
Net Income 5 Year Avg. Growth - 21.26 % 10.49 % 3.58 %

HZNP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 107.41 % -91.17 % -94.18 % -12.23 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 133.33 % -82.8 % -93.7 % -5.88 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -43.01 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 17.79 % - - 31714.25 %
EPS from Cont. Ops. 5 Year Avg. Growth - 4.93 % 8.32 % 11.88 %



HZNP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 107.69 % -91.09 % -94.3 % -10.4 %
Q / Q EPS Net Growth (Q2 MRQ) 134.78 % -82.53 % -93.84 % -4.29 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 22065.17 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 17.72 % - - 27229.2 %
EPS Net 5 Year Avg. Change - 21.26 % 10.49 % 3.58 %



Despite the -91.09% decline in Major Pharmaceutical Preparations industry, Horizon Therapeutics Public Limited showed impressive surge in EPS in the second quarter by 107.69% from the same quarter a year ago, to $0.54, Healthcare sector dropped -94.3%. Despite modest earnings per share in the Major Pharmaceutical Preparations industry and ind the Healthcare sector, Horizon Therapeutics Public Limited Company reported above average market earnings per share growth.

The Company's sequential EPS growth rate was very impressive 134.78% from the first quarter. Average yearly income per share growth for Horizon Therapeutics Public Limited is 28%, while S & P 500's average annual income per share growth is 3.58% over the five years, including only Businesses with the second quarter 2023 earnings results.

HZNP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) -40.18 % -49.17 % -27.32 % -22.48 %
Sequential Free Cash Flow Change (Q2 MRQ) 129.92 % 20.4 % 80.48 % 98.02 %
Y / Y Free Cash Flow Change (Q2 TTM) -28.79 % -32.09 % -30.73 % -12.48 %
Sequential Free Cash Flow Change (Q2 TTM) -9.11 % -11.57 % -6.96 % -8.48 %
Free Cash Flow 5 Year Avg. Change 34.04 % 8.35 % 6.34 % -24.89 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) -38.8 % - - -
Sequential Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) -47.08 % - - -
Sequential Net Cash Flow Change (Q2 TTM) - - 26.8 % -
Net Cash Flow 5 Year Avg. Change 26.13 % - -32.87 % 34.23 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 81.86 % 12.29 % 5.4 % 12.07 %
Sequential Capital Expenditures Change (Q2 MRQ) -23.47 % -0.47 % -1.66 % 4.78 %
Y / Y Capital Expenditures Change (Q2 TTM) 19.76 % 12.95 % 6.18 % -27.68 %
Sequential Capital Expenditures Change (Q2 TTM) 11.24 % 0.62 % 0.96 % -14.07 %
Capital Expenditures 5 Year Avg. Change 71.35 % 13.35 % 9.54 % 8.45 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.